{"id":"https://openalex.org/W4405034603","doi":"https://doi.org/10.1182/blood-2024-194239","title":"Clinical Benefits of Achieving Hemoglobin (Hb) Levels \u2265 10 g/dL in Transfusion-Dependent (TD) Erythropoiesis-Stimulating Agent (ESA)-Naive Patients (Pts) with Lower-Risk (LR) Myelodysplastic Syndromes (MDS) Treated with Luspatercept in the COMMANDS Trial","display_name":"Clinical Benefits of Achieving Hemoglobin (Hb) Levels \u2265 10 g/dL in Transfusion-Dependent (TD) Erythropoiesis-Stimulating Agent (ESA)-Naive Patients (Pts) with Lower-Risk (LR) Myelodysplastic Syndromes (MDS) Treated with Luspatercept in the COMMANDS Trial","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405034603","doi":"https://doi.org/10.1182/blood-2024-194239"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-194239","doi":"https://doi.org/10.1182/blood-2024-194239","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-194239","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1818/2328212/blood-4565-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1818/2328212/blood-4565-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091318797","display_name":"Valeria Santini","orcid":"https://orcid.org/0000-0002-5439-2172","observed_orcids":["https://orcid.org/0000-0002-5439-2172"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valeria Santini","raw_affiliation_strings":["1University of Florence Medical School, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Florence Medical School, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067521829","display_name":"Amer Methqal Zeidan","orcid":"https://orcid.org/0000-0001-7017-8160","observed_orcids":["https://orcid.org/0000-0001-7017-8160"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amer M. Zeidan","raw_affiliation_strings":["2Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079124367","display_name":"Uwe Platzbecker","orcid":"https://orcid.org/0000-0003-1863-3239","observed_orcids":["https://orcid.org/0000-0003-1863-3239"]},"institutions":[{"id":"https://openalex.org/I4210125843","display_name":"University Hospital Leipzig","ror":"https://ror.org/028hv5492","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210125843"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe Platzbecker","raw_affiliation_strings":["3University Hospital Leipzig, Leipzig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University Hospital Leipzig, Leipzig, Germany","institution_ids":["https://openalex.org/I4210125843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S. Komrokji","raw_affiliation_strings":["4Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084870748","display_name":"Dimana Miteva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47396830","display_name":"Bristol-Myers Squibb (Switzerland)","ror":"https://ror.org/02xqc6638","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I47396830"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Dimana Miteva","raw_affiliation_strings":["6Bristol Myers Squibb, Boudry, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bristol Myers Squibb, Boudry, Switzerland","institution_ids":["https://openalex.org/I47396830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012489162","display_name":"Aylin Y\u00fccel","orcid":"https://orcid.org/0000-0002-7442-4549","observed_orcids":["https://orcid.org/0000-0002-7442-4549"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aylin Yucel","raw_affiliation_strings":["7Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020776499","display_name":"Veronika Pozharskaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Veronika Pozharskaya","raw_affiliation_strings":["7Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112451928","display_name":"Shelonitda Rose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shelonitda Rose","raw_affiliation_strings":["7Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069105876","display_name":"Yinzhi Lai","orcid":"https://orcid.org/0000-0003-0131-2172","observed_orcids":["https://orcid.org/0000-0003-0131-2172"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yinzhi Lai","raw_affiliation_strings":["7Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114104697","display_name":"Ana Carolina Giuseppi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Carolina Giuseppi","raw_affiliation_strings":["7Bristol Myers Squibb, Princeton, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Bristol Myers Squibb, Princeton, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020211212","display_name":"David Valc\u00e1rcel","orcid":"https://orcid.org/0000-0002-8747-078X","observed_orcids":["https://orcid.org/0000-0002-8747-078X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Valc\u00e1rcel Ferreiras","raw_affiliation_strings":["8Hospital Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Hospital Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014838075","display_name":"Pierre Fenaux","orcid":"https://orcid.org/0000-0002-0468-3553","observed_orcids":["https://orcid.org/0000-0002-0468-3553"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I40434647","https://openalex.org/I4210124654","https://openalex.org/I4387154366","https://openalex.org/I48825208"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Fenaux","raw_affiliation_strings":["9Service d'H\u00e9matologie S\u00e9niors, H\u00f4pital Saint-Louis, Universit\u00e9 Paris 7, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Service d'H\u00e9matologie S\u00e9niors, H\u00f4pital Saint-Louis, Universit\u00e9 Paris 7, Paris, France","institution_ids":["https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057674362","display_name":"Jake Shortt","orcid":"https://orcid.org/0000-0003-3185-6488","observed_orcids":["https://orcid.org/0000-0003-3185-6488"]},"institutions":[{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jake Shortt","raw_affiliation_strings":["10Monash University and Monash Health, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Monash University and Monash Health, Melbourne, Australia","institution_ids":["https://openalex.org/I4210121067","https://openalex.org/I56590836"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052225546","display_name":"Matteo Giovanni Della Porta","orcid":"https://orcid.org/0000-0002-1984-1614","observed_orcids":["https://orcid.org/0000-0002-1984-1614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matteo Giovanni Della Porta","raw_affiliation_strings":["11Humanitas University, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Humanitas University, Milan, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"1818","last_page":"1818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9053000211715698,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9053000211715698,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.032600000500679016,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/luspatercept","display_name":"luspatercept","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lower-risk-myelodysplastic-syndromes","display_name":"lower-risk myelodysplastic syndromes","score":0.9160000085830688},{"id":"https://openalex.org/keywords/transfusion-dependent-patients","display_name":"transfusion-dependent patients","score":0.5659999847412109},{"id":"https://openalex.org/keywords/hemoglobin-target","display_name":"hemoglobin target","score":0.5},{"id":"https://openalex.org/keywords/red-blood-cell-transfusion-independence","display_name":"red blood cell transfusion independence","score":0.9160000085830688},{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.8830000162124634},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7710000276565552},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.753000020980835},{"id":"https://openalex.org/keywords/anemia-treatment","display_name":"anemia treatment","score":0.414000004529953},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.7678074836730957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6881132125854492},{"id":"https://openalex.org/C2779703530","wikidata":"https://www.wikidata.org/wiki/Q837174","display_name":"Erythropoiesis","level":3,"score":0.6233764290809631},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.6055129766464233},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.5666612386703491},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5363598465919495},{"id":"https://openalex.org/C2780844101","wikidata":"https://www.wikidata.org/wiki/Q2380264","display_name":"Ineffective erythropoiesis","level":4,"score":0.4697335660457611},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.4209415018558502},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4050334095954895},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.2205912470817566}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-194239","doi":"https://doi.org/10.1182/blood-2024-194239","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-194239","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1818/2328212/blood-4565-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2024-194239","doi":"https://doi.org/10.1182/blood-2024-194239","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-194239","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1818/2328212/blood-4565-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320310276","display_name":"Helsinn","ror":"https://ror.org/01kdzkq48"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320314605","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38"},{"id":"https://openalex.org/F4320315426","display_name":"BioCryst","ror":"https://ror.org/031mgj447"},{"id":"https://openalex.org/F4320316629","display_name":"Agios Pharmaceuticals","ror":"https://ror.org/002x06r10"},{"id":"https://openalex.org/F4320317479","display_name":"CTI Biopharma","ror":"https://ror.org/017bk0e71"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320327470","display_name":"Swedish Orphan Biovitrum","ror":"https://ror.org/04asvbz37"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405034603.pdf","grobid_xml":"https://content.openalex.org/works/W4405034603.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2065589830","https://openalex.org/W2120269793","https://openalex.org/W4312222043","https://openalex.org/W2154504105","https://openalex.org/W2118103190","https://openalex.org/W2977564049","https://openalex.org/W2064228685","https://openalex.org/W2128706348","https://openalex.org/W2036967678","https://openalex.org/W2801725202"],"abstract_inverted_index":{"Introduction":[0],"Treatment":[1],"(tx)":[2],"goals":[3],"in":[4,58,71,82,105,116,154,161,279,312,547,554,565,571,581,594,620,631,713],"pts":[5,28,60,117,158,296,320,384,405,448,471,488,532,595,632,662,714],"with":[6,29,61,74,109,118,159,298,328,473,519,693,715],"LR-MDS":[7,30,119,160],"are":[8],"to":[9,39,51,195,202,218,484,509],"increase":[10,78,580],"Hb":[11,53,77,112,136,150,248,267,331,395,476,492,511,665,682,695],"levels,":[12],"achieve":[13],"red":[14],"blood":[15],"cell":[16],"(RBC)":[17],"transfusion":[18],"independence":[19],"(TI),":[20],"and":[21,141,152,187,239,242,276,290,310,376,436,500,522,541,627],"improve":[22],"quality":[23],"of":[24,34,111,134,145,174,235,264,317,365,381,426,461,591,600,622,637,674,690,709],"life":[25],"(QoL).":[26],"Many":[27],"have":[31],"short":[32],"duration":[33,364,425],"response":[35,67,344,357,366,409,419,427],"or":[36,178,211,583,688],"become/are":[37],"refractory":[38],"ESAs.":[40],"In":[41,99,528],"the":[42,131,143,162,254,280,346,359,411,421,516,566,706],"phase":[43],"3":[44,209,256,260],"COMMANDS":[45,163,658],"trial":[46],"(NCT03682536),":[47],"tx":[48,265],"dosing":[49,517],"aimed":[50],"maintain":[52,510],"level":[54,137,249],"at":[55,345,358,410,420,496,558,697],"10\u221212":[56],"g/dL":[57,81,115,140,495,514,669],"ESA-naive":[59,156],"TD":[62,155,188],"LR-MDS.":[63,716],"Luspatercept":[64,677],"demonstrated":[65],"superior":[66],"vs":[68,86],"epoetin":[69,212],"alfa":[70,213],"RBC":[72],"TI":[73],"concurrent":[75,329,393],"mean":[76,330,394,491],"\u2265":[79,113,138,237,245,305,323,332,387,396,493,512,667],"1.5":[80],"weeks":[83,210,241,261,307,325,389,430,438],"1-24":[84],"(60.4%":[85],"34.8%,":[87],"P":[88],"<":[89],"0.0001;":[90],"Della":[91],"Porta":[92],"MG,":[93],"et":[94,122,454],"al.":[95,123,455],"Lancet":[96],"Haem":[97],"2024.":[98,126,458],"press).":[100],"Previously,":[101],"clinically":[102,578,671],"significant":[103,579,618],"improvement":[104,151],"QoL":[106],"was":[107,250,367,428,467,556,576,629],"observed":[108,630],"achievement":[110,234],"10":[114,139,333,397,494,513,668],"(Oliva":[120],"E,":[121],"EHA":[124,456],"Library":[125,457],"P774).":[127],"Here,":[128],"we":[129],"assess":[130],"clinical":[132,707],"benefits":[133],"achieving":[135],"analyze":[142],"effects":[144],"luspatercept":[146,197,281,497,535,560,567,601,638,710],"dose":[147,222,287,450,482,503,561,678,711],"escalation":[148,451,483,679,712],"on":[149,271],"safety":[153,277],"luspatercept-treated":[157,661],"trial.":[164],"Methods":[165],"Pts":[166,191,692],"(\u2265":[167],"18":[168],"years)":[169],"who":[170,489,533,596,633,663],"had":[171,501,670],"a":[172,355,407,417,700],"diagnosis":[173],"very":[175],"low-,":[176,177],"intermediate-risk":[179],"MDS":[180],"(per":[181],"Revised":[182],"International":[183],"Prognostic":[184],"Scoring":[185],"System)":[186],"were":[189,192,269,283,301,507,545,569],"enrolled.":[190],"randomized":[193],"1:1":[194],"receive":[196],"1.0":[198],"mg/kg":[199,499,521,524],"(titration":[200,216],"up":[201,217],"1.75":[203,291,485,523,612,649],"mg/kg)":[204],"subcutaneously":[205],"(SC)":[206],"once":[207,226],"every":[208,259],"450":[214],"IU/kg":[215],"1050":[219],"IU/kg,":[220],"maximum":[221,286],"80,000":[223],"IU)":[224],"SC":[225],"weekly.":[227],"Key":[228],"secondary":[229],"endpoints":[230],"(weeks":[231],"1\u221224)":[232],"included":[233,311],"RBC-TI":[236,304,322,386],"12":[238,306,324,388,403],"24":[240],"hematologic":[243],"improvement-erythroid":[244],"8":[246,479],"weeks.":[247],"assessed":[251],"weekly":[252],"for":[253,303,374,434,442],"first":[255],"weeks,":[257],"then":[258],"until":[262],"end":[263],"[EOT].":[266],"outcomes":[268,278],"analyzed":[270],"rolling":[272],"12-wk":[273],"intervals.":[274],"Efficacy":[275],"arm":[282],"explored":[284],"by":[285],"(1.0,":[288],"1.33,":[289],"mg/kg).":[292],"Results":[293],"Of":[294,399],"182":[295],"treated":[297],"luspatercept,":[299],"139":[300],"responders":[302],"(week":[308,326,390],"1-EOT)":[309,327,391],"this":[313],"analysis.":[314],"A":[315,379,465],"total":[316,380],"108/139":[318],"(77.7%)":[319],"achieved":[321,385,490,664],"g/dL.":[334,398],"Among":[335,487],"these":[336,400],"luspatercept-responsive":[337],"pts,":[338,402],"92/108":[339],"(85.2%)":[340],"maintained":[341,354,406,416,680],"their":[342,462],"longest":[343,375,408,435],"cutoff":[347,361,412,422],"date":[348],"(Sept":[349],"22,":[350],"2023);":[351],"99/108":[352],"(91.7%)":[353],"cumulative":[356,377,418,443],"data":[360],"date;":[362,413,423],"median":[363,424],"not":[368],"reached":[369],"(NR;":[370],"95%":[371],"CI":[372,432,440],"NR\u2212NR)":[373],"response.":[378,444],"31/139":[382],"(22.3%)":[383],"without":[392,684],"31":[401],"(38.7%)":[404,415],"12/31":[414],"37.0":[429],"(95%":[431,439],"22.6\u221276.4)":[433],"41.4":[437],"23.9\u221289.9)":[441],"Overall,":[445],"most":[446],"(80.2%)":[447],"required":[449],"(Santini":[452],"V,":[453],"P785)":[459],"regardless":[460],"baseline":[463,475,698],"characteristics.":[464],"trend":[466,701],"noted":[468],"showing":[469],"more":[470],"(63.0%)":[472],"lower":[474,694],"levels":[477,666,683,696],"(<":[478],"g/dL)":[480],"needed":[481],"mg/kg.":[486],"1":[498],"subsequent":[502],"escalation,":[504],"approximately":[505],"50%":[506],"able":[508],"during":[515],"period":[518],"1.33":[520,607,644],"combined":[525],"(17/29":[526],"[58.6%]).":[527],"total,":[529],"178/182":[530],"(97.8%)":[531],"received":[534,597,634],"experienced":[536],"tx-emergent":[537],"adverse":[538],"events":[539],"(TEAEs)":[540],"grade":[542,623],"3/4":[543,624],"TEAEs":[544,555,564,593,626],"reported":[546,557,570],"117/182":[548],"(64.3%)":[549],"pts;":[550],"no":[551,577],"noticeable":[552],"difference":[553,619],"different":[559],"levels.":[562],"Tx-related":[563],"group":[568],"64":[572],"(35.2%)":[573],"pts.":[574],"There":[575],"frequency":[582],"exposure-adjusted":[584],"incidence":[585,621,687],"rate":[586],"(EAIR;":[587],"per":[588],"100":[589],"patient-years)":[590],"tx-related":[592,625],"higher":[598,635,703],"doses":[599,636],"(1.0":[602,639],"mg/kg:":[603,608,613,640,645,650],"30.1%,":[604],"EAIR":[605,610,615,628,642,647,652],"29.1;":[606],"41.7%,":[609],"52.5;":[611],"35.6%,":[614],"32.7).":[616],"No":[617],"7.5%,":[641],"6.0;":[643],"12.5%,":[646],"10.2;":[648],"8.5%,":[651],"5.9).":[653],"Conclusions":[654],"This":[655],"analysis":[656],"from":[657],"indicates":[659],"that":[660],"meaningful":[672],"rates":[673],"durable":[675],"RBC-TI.":[676],"target":[681],"significantly":[685],"increasing":[686],"severity":[689],"TEAEs.":[691],"showed":[699],"requiring":[702],"dose,":[704],"supporting":[705],"benefit":[708]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}